Dosidal · Norway

Qarziba kons til inf oppl 4,5 mg/ml

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketNorway
Recordno:presentation:varenr:043759 (version 1)
Levelpresentation
Pack codegtin: 05060146292108
Identifiersno-varenr: 043759
gtin: 5060146292108
gtin-nordic-rule: 7046260437593
Source authorityNOMA
Read date2026-11-15T02:50:45Z
controlled statusreseptgruppe: C
rule_source: https://www.helsedirektoratet.no/veiledere/rekvirering-og-utlevering-av-legemidler-m.m/krav-til-innhold-i-resepter-og-rekvisisjoner/-5-8-saerregler-for-resept-for-legemidler-i-reseptgruppe-a-og-b
special_prescribing_rules_A_or_B: False
state: current · read 2026-11-15T02:50:45Z · source: NOMA (FEST) page
identityatc: L01FX06
atc_text: Dinutuksimab beta
brand: Qarziba
company: Recordati Netherlands B.V.
form: Konsentrat til infusjonsvæske, oppløsning
hospital_product: False
name: Qarziba kons til inf oppl 4,5 mg/ml
pack_size: 1 x 20
pack_type: Hetteglass
pack_unit: milligram
product_type: Legemiddel
substances: strength: 4.5 mg
substance: Dinutuksimab beta
substitution_group: False
varenr: 043759
state: current · read 2026-11-15T02:50:45Z · source: NOMA (FEST) page
pack product codenordic_rule_gtin: 7046260437593
nordic_rule_note: 704626 + item number + check digit (CEO Nordic ruling); may not be the printed code
published_gtins: check_digit_valid: True
gtin: 5060146292108
varenr: 043759
state: current · read 2026-11-15T02:50:45Z · source: NOMA (FEST) page
prescription classlabel: Reseptgruppe C
prescription: True
reseptgruppe: C
state: current · read 2026-11-15T02:50:45Z · source: NOMA (FEST) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
yI_SAa5XotEJk_BO8jVFz5koj1_EB3_9mqHa2eHwTFlFPv8vvLexVDehR7LZ_hfuzC7HFKi9JamjN9TzBnUjtw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal